Here are today's top Wall Street analyst ratings where finbox.io's unbiased fair value estimates support the recommendation.
Top Upgrades and Buy Ratings
JPMorgan Chase reiterated Fresenius Medical Care (NYSE:FMS) at Buy. Shares currently have 20% upside.
RBC Capital raised its price target for GMS (NYSE:GMS) to $32 per share and set an Outperform rating. Finbox.io's six valuation analyses also conclude a $32 intrinsic value implying almost 18% upside.
Piper Jaffray upgraded Kroger (NYSE:KR) from Underweight to Neutral. The new rating is generally supported by the company's fundamentals.
Citigroup upgraded Vectren Corp. (NYSE:VVC) from Neutral to Buy. Nine valuation models imply a fair value of $59 per share implying the stock is currently 13% undervalued.
Sandler O'Neill downgraded Liberty Property Trust (NYSE:LPT) from Hold to Sell. Shares are currently trading at a 11% premium.
Morgan Stanley downgraded Zayo Group Holdings (NYSE:ZAYO) from Overweight to Equal Weight. Five valuation models imply the stock is 8% overvalued.
William Blair downgraded ICF International (Nasdaq:ICFI) from Outperform to Market Perform. Shares traded lower by nearly 7% following the downgrade. Ten valuation models conclude that the company still has a negative 5% margin of safety.